EMPIRE CONSULTING GROUP

Lobbying for GILEAD SCIENCES INC. · Biopharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 19, 2025

Lobbying activity 1

Health Issues

PBM reform. PEPFAR funding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem